Osteosarcoma OsteoBites S2 Ep 17: Lara Davis, MD, OHSU Knight Cancer Institute “New Osteosarcoma Clinical Trials” episode artwork

EPISODE · Jun 17, 2021 · 47 MIN

Osteosarcoma OsteoBites S2 Ep 17: Lara Davis, MD, OHSU Knight Cancer Institute “New Osteosarcoma Clinical Trials”

from MIB Agents OsteoBites and osTEAo · host MIB Agents Osteosarcoma

MIB Agents OsteoBites S2 Ep 17: Lara Davis, MD, OHSU Knight Cancer Institute “New Osteosarcoma Clinical Trials” ... Guest Information: Lara E. Davis, MD Associate Professor Knight Cancer Institute Co-Leader, Translational Oncology Research Program Sarcoma Disease Site Leader Oregon Health & Science University Lara Davis, MD graduated from Wellesley College and then went on to receive her medical degree from OHSU. After training in a dual Internal Medicine and Pediatrics residency program at Harvard, she returned to Portland to complete a combined Adult and Pediatric Oncology fellowship with a focus on Adolescents and Young Adults (AYAs). Dr. Davis joined the faculty at OHSU in 2013, where she is a member of the Knight Cancer Institute with dual appointments in the Division of Medical Oncology and Pediatric Hematology/Oncology. She focuses exclusively on sarcoma in both the clinic and in the laboratory. ... Hosted by: Ann Graham OsteoWarrior and Executive Director of MIB Agents. Panelists: Annika Vallejo - MIB Junior Board Member & Osteosarcoma Sibling Valerie Nguyen - MIB Junior Board Member & Osteosarcoma Sibling … Next week we will be talking with Dr. Richard Gorlick on “Antibody Drug Conjugates”, Dr. Gorlick is the Division Head, Division of Pediatrics, The University of Texas MD Anderson Cancer Center, And Professor, Department of Pediatrics at The University of Texas MD Anderson Cancer Center, he is also a pediatric cancer survivor!  We are looking forward to this conversation ... LINKS OutRunning Osteosarcoma: www.mibagents.org/outrunning OutBidding Osteosarcoma:  www.mibagents.org/outbidding SarcTrials.org More Information on trials discussed Email:  [email protected] … What We Do at MIB Agents: PROGRAMS: ✨ End-of-Life MISSIONS ✨ Gamer Agents ✨ Agent Writers ✨ Prayer Agents ✨ Healing Hearts Bereaved Parent Support ✨ Ambassador Agents - Peer Support EDUCATION for physicians, researchers and families: ✨ OsteoBites, weekly webinar & podcast with thought leaders and innovators in Osteosarcoma ✨ MIB Book: Osteosarcoma: From our Families to Yours RESEARCH: ✨ Annual MIB FACTOR Research Conference ✨ Funding $100,000 annually for OS research ✨ MIB Testing & Research Directory ✨ The Osteosarcoma Project partner with Broad Institute of MIT and Harvard ... Kids are still dying with 40+ year old treatments. Help us MakeItBetter. 🔗 https://www.mibagents.org ✨✨SUBSCRIBE for all the Osteosarcoma Intel ✨✨

Episode metadata supplied by the publisher feed · Published Jun 17, 2021

Embed this episode

NOW PLAYING

Osteosarcoma OsteoBites S2 Ep 17: Lara Davis, MD, OHSU Knight Cancer Institute “New Osteosarcoma Clinical Trials”

0:00 47:52

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of MIB Agents OsteoBites and osTEAo?

This episode is 47 minutes long.

When was this MIB Agents OsteoBites and osTEAo episode published?

This episode was published on June 17, 2021.

Can I download this MIB Agents OsteoBites and osTEAo episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!